Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

Filter by
  • Filter by
  • Remove this filter Type: Publication
  • Remove this filter Public health area: Surveillance
  • Infectious disease
    • Vaccine preventable diseases (645)
    • Respiratory diseases (419)
    • Influenza (284)
    • Food- and waterborne diseases (226)
    • Sexually transmitted infections (224)
    • Zoonosis (219)
    • Mosquito-borne diseases (136)
    • HIV infection (132)
    • Acquired immunodeficiency syndrome (AIDS) (132)
    • Flu (125)
    • Seasonal influenza (125)
    • Influenza in humans, seasonal (125)
    • Tuberculosis (111)
    • Measles (92)
    • Viral hepatitis (83)
    • Healthcare-associated infections (79)
    • Rubella (72)
    • German measles (72)
    • Viral haemorrhagic fever (68)
    • Zoonotic influenza (61)
    • Avian influenza virus (59)
    • Dengue (50)
    • West Nile virus infection (46)
    • Ebola haemorrhagic fever (46)
    • Salmonellosis (44)
    • Hepatitis A (40)
    • Chikungunya virus disease (39)
    • Middle East respiratory syndrome coronavirus (39)
    • Poliomyelitis (38)
    • Coronavirus (37)
    • Influenza in humans, avian origin (35)
    • Gonorrhoea (35)
    • Nosocomial infections (34)
    • Influenza A (H1N1) (34)
    • Legionnaires’ disease (33)
    • Vector organisms (33)
    • Hepatitis B (31)
    • Multidrug-resistant tuberculosis (31)
    • Hepatitis (31)
    • Influenza A (H9N2) (31)
    • SARS-CoV-2 (30)
    • COVID-19 (30)
    • Avian influenza in humans (30)
    • Chlamydia infection (27)
    • Campylobacteriosis (27)
    • Hepatitis C (26)
    • Hospital-acquired infections (26)
    • Tick-borne diseases (25)
    • Influenza A (H1N1)2009 (25)
    • Invasive pneumococcal disease (24)
    • S. pneumoniae (24)
    • Streptococcus pneumoniae (24)
    • Pneumococcal disease (24)
    • Mosquitoes (24)
    • Zika virus disease (24)
    • Escherichia coli infection (24)
    • Syphilis (23)
    • Vector-borne disease (23)
    • Listeriosis (22)
    • Influenza in humans, pandemic (21)
    • Whooping cough (19)
    • Yellow fever (19)
    • Pertussis (19)
    • Cholera (18)
    • Influenza in humans, swine origin (18)
    • Yersiniosis (17)
    • Malaria (16)
    • Ebola outbreak - North Kivu, DRC (16)
    • Verotoxigenic Escherichia coli infection (15)
    • Shiga toxin producing Escherichia coli (STEC) infection (15)
    • Verocytotoxigenic Escherichia coli (VTEC) infection (15)
    • Clostridium difficile infection (14)
    • Enterohaemorrhagic Escherichia coli (EHEC) infection (14)
    • Shigellosis (13)
    • Emerging disease (13)
    • Q fever (12)
    • Rabies (12)
    • Mumps (12)
    • Lymphogranuloma venereum (12)
    • Influenza A(H7N9) virus (12)
    • Invasive meningococcal disease (11)
    • Surgical site infections (11)
    • Tick-borne encephalitis (TBE) (11)
    • Meningococcal disease (11)
    • Tularaemia (11)
    • Trichinellosis (11)
    • Rift Valley fever (10)
    • Invasive Haemophilus influenzae disease (10)
    • Haemophilus infection (10)
    • Brucellosis (9)
    • Echinococcosis (9)
    • Toxoplasmosis, congenital (9)
    • Infections in intensive care units (9)
    • Hydatidosis (9)
    • Influenza A(H5N1) virus (9)
    • Paratyphoid fever (8)
    • Klebsiella pneumoniae (8)
    • Influenza A(H5N8) virus (8)
    • Chickenpox (8)
    • Enteric fever (8)
    • Infections in long-term care facilities (8)
    • Varicella (8)
    • Typhoid and paratyphoid fever (8)
    • Haemorrhagic fever with renal syndrome (7)
    • Syphilis, congenital (7)
    • Hantavirus infection (7)
    • Nephropathia epidemica (7)
    • Congenital syphilis (7)
    • Carbapenem-resistant Enterobactericae (7)
    • Drug-resistant tuberculosis (7)
    • Hepatitis E (7)
    • Cryptosporidiosis (7)
    • Tetanus (7)
    • Ticks (6)
    • Influenza A(H5N2) virus (6)
    • Borreliosis (6)
    • Marburg virus diseases (6)
    • Lyme disease (6)
    • Vibrio (6)
    • Extensively drug-resistant tuberculosis (XDR-TB) (6)
    • Plague (6)
    • Diphtheria (6)
    • Marburg haemorrhagic fever (6)
    • Crimean-Congo haemorrhagic fever (6)
    • Smallpox (6)
    • Congenital rubella (5)
    • Latent tuberculosis infection (5)
    • Coxsackievirus (5)
    • Creutzfeldt-Jakob disease (5)
    • Infections in acute care hospitals (5)
    • Extrapulmonary tuberculosis (5)
    • Lassa fever (5)
    • Variant Creutzfeldt-Jakob disease (vCJD) (5)
    • Giardiasis (5)
    • Leptospirosis (5)
    • Botulism (5)
    • Anthrax (5)
    • Enterovirus (5)
    • Foodborne diseases (4)
    • Haemorrhagic fever (4)
    • Ebola outbreak - Guinea (4)
    • Sandfly (3)
    • Phlebotomus (3)
    • Norovirus infection (3)
    • Methicillin-resistant Staphylococcus aureus (MRSA) (3)
    • Severe acute respiratory syndrome (SARS) (3)
    • Disease vector (2)
    • Acinetobacter (2)
    • Influenza A(H5N6) (2)
    • Swine-origin influenza (2)
    • Bilharziasis (2)
    • Snail fever (2)
    • Schistosomiasis (2)
    • Zika virus disease - Outbreak in the Americas (2)
    • Japanese encephalitis virus (2)
    • Waterborne diseases (2)
    • Leishmaniasis (2)
    • Sandfly-borne diseases (2)
    • Louse-borne diseases (1)
    • Ebola outbreak - West Africa (1)
    • Rickettsiosis (1)
    • Tick-borne relapsing fever (1)
    • Ventilator-associated pneumonia (1)
    • Guillain-Barré syndrome (1)
    • Candida auris (1)
  • Public health area
    • Surveillance (1258)
    • Epidemiology (188)
    • Prevention and control (172)
    • Disease prevention (171)
    • Prophylaxis (171)
    • Public health threat (142)
    • Outbreak (142)
    • Threats and outbreaks (142)
    • Immunisation (99)
    • Vaccination (99)
    • Active immunisation (99)
    • Microbiology (94)
    • Epidemic (88)
    • Antimicrobial resistance (83)
    • Antibiotic resistance (83)
    • Laboratories (44)
    • Determinant (41)
    • Public health response (39)
    • Control campaign (39)
    • Molecular typing (28)
    • Transmission of disease (28)
    • Preparedness (24)
    • Reference laboratory (20)
    • Laboratory based surveillance (20)
    • Antimicrobial consumption (19)
    • Climate change (18)
    • Diagnostic test (17)
    • Epidemic intelligence (16)
    • Migrant health (13)
    • Vaccine effectiveness (13)
    • Pandemic preparedness (11)
    • Mass gathering (11)
    • Training (10)
    • Vaccine safety (10)
    • Preventive measure (10)
    • Health communication (9)
    • Scientific advice (9)
    • Whole genome sequencing (9)
    • Hospital infection control (7)
    • Vaccination coverage (6)
    • Pregnant women (6)
    • Country cooperation (5)
    • Case management (5)
    • HIV testing (5)
    • Infectious diseases on aircrafts (4)
    • Point prevalence survey (4)
    • People who inject drugs (PWID) (4)
    • Travellers' health (4)
    • Antimicrobial stewardship (4)
    • Intravenous drug users (4)
    • Laboratory capacity (4)
    • National reference laboratory (4)
    • Injecting drug users (IDUs) (4)
    • Laboratory quality (3)
    • Hand hygiene (3)
    • Multidrug resistance (3)
    • Antiviral (3)
    • Burden of communicable diseases (2)
    • Risk communication (2)
    • High-risk groups (2)
    • Crisis communication (2)
    • Health inequality (2)
    • Childhood vaccination (2)
    • Biosafety (1)
    • Public health education (1)
    • Vaccine efficacy (1)
    • Intensive care unit (ICU) (1)
    • Vaccine hesitancy (1)
    • Blood safety (1)
  • Country
    • Europe (836)
    • Asia (50)
    • Africa (34)
    • Americas (14)
    • North America (8)
    • EU Candidate Countries (5)
    • European Neighbourhood Policy countries (2)
    • Pacific regions (2)
    • Nothern Africa (1)
    • Indian Ocean (1)
  • Media type
    • Publication (1258)
    • Surveillance report (616)
    • Peer-reviewed publication (443)
    • Technical report (87)
    • Technical guidance (30)
    • Presentation (24)
    • Meeting report (22)
    • Risk assessment (14)
    • External quality assessment (9)
    • Corporate publication (5)
    • Toolkit (2)
    • Literature review (2)
    • Mission report (1)
    • Data (1)
    • Graph (1)
    • Map (1)
    • Factsheet (1)
  • Page 1 of 126 // 1258 Results found
    • Sort by:

Publication

Hantavirus infection - Annual Epidemiological Report for 2019

Surveillance report - 22 Apr 2021

For 2019, 29 countries reported 4 046 cases of hantavirus infection (0.8 cases per 100 000 population), mainly caused by Puumala virus (98%).

Hantavirus infection - Annual Epidemiological Report for 2019 - EN - [PDF-874.06 KB]
  • Hantavirus infection
  • Surveillance

Publication

Malaria - Annual Epidemiological Report for 2019

Surveillance report - 22 Apr 2021

For 2019, 8 641 malaria cases were reported in the EU/EEA, 8 638 (> 99%) of which were confirmed.

Malaria - Annual Epidemiological Report for 2019 - EN - [PDF-950.27 KB]
  • Malaria
  • Surveillance

Publication

Influenza virus characterisation - Summary Europe, March 2021

Surveillance report - 21 Apr 2021

This is the fifth report for the 2020-2021 influenza season. As of week 12/2021, only 758 influenza detections across the WHO European Region had been reported to The European Surveillance System (TESSy); 50% type A viruses, with A(H3N2) and A(H1N1)pdm09 being equally represented, and 50% type B viruses, with only 12 having been ascribed to a lineage, 10 B/Victoria and two B/Yamagata.

Influenza virus characterisation - Summary Europe, March 2021 - EN - [PDF-2.19 MB]
  • EU/EEA
  • Influenza
  • Influenza in humans, seasonal
  • Surveillance

Publication

Chikungunya virus disease - Annual Epidemiological Report for 2019

Surveillance report - 14 Apr 2021

For 2019, 15 countries reported 516 cases of chikungunya virus disease, of which 421 (82%) were confirmed.

Chikungunya virus disease - Annual Epidemiological Report for 2019 - EN - [PDF-494.23 KB]
  • Chikungunya virus disease
  • EU/EEA
  • Surveillance

Publication

Dengue - Annual Epidemiological Report for 2019

Surveillance report - 14 Apr 2021

For 2019, 27 countries reported 4 363 cases of dengue, of which 4 020 (92%) were confirmed. • The number of cases in 2019 was almost double that for 2018, reflecting the intense circulation of the virus on a global scale.

Dengue- Annual Epidemiological Report for 201 9 - EN - [PDF-504.57 KB]
  • Dengue
  • EU/EEA
  • Surveillance

Publication

Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA

Technical report - 8 Apr 2021

The aim of this document is to present the findings of a survey of EU/EEA countries carried out to ascertain
surveillance practices implemented to document and report suspected reinfection cases.

Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA - EN - [PDF-860.08 KB]
  • Coronavirus
  • COVID-19
  • Public health threat
  • Scientific advice
  • Surveillance

Publication

Communicable disease threats report, 28 March-3 April 2021, week 13

Publication - 1 Apr 2021

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 28 March-3 April 2021 and includes updates on COVID-19, Influenza A(H1N1) variant and Ebola virus disease.

Communicable disease threats report, 28 March-3 April 2021, week 13 - EN - [PDF-1.85 MB]
  • Coronavirus
  • COVID-19
  • Democratic Republic of the Congo
  • Ebola haemorrhagic fever
  • Ebola outbreak - Guinea
  • Ebola outbreak - North Kivu, DRC
  • EU/EEA
  • Guinea
  • Influenza
  • Influenza in humans, swine origin
  • Public health threat
  • Surveillance
  • United States

Publication

The sustainable development goals and hepatitis B and C in the EU/EEA

Technical report - 29 Mar 2021

In order to monitor progress towards the United Nations Sustainable Development Goals 2030 target to combat viral hepatitis, this report provides data on hepatitis B and C prevention, incidence, diagnosis, treatment, cure/viral suppression, and mortality in European Union/European Economic Area (EU/EEA) countries with data collected in 2019.

The sustainable development goals and hepatitis B and C in the EU/EEA - EN - [PDF-919.99 KB]
  • EU/EEA
  • Hepatitis B
  • Hepatitis C
  • Prevention and control
  • Surveillance
  • Viral hepatitis

Publication

Zika virus disease - Annual Epidemiological Report for 2019

Surveillance report - 24 Mar 2021

For 2019, in the EU/EEA countries, 71 cases of Zika virus (ZIKV) disease were reported. Five cases of ZIKV disease were reported to have been locally-acquired, three autochthonous vector-borne cases, one case of sexual transmission and one case of non-mosquito borne transmission. 92% of cases of ZIKV disease with known importation status were from returning travellers.

Zika virus disease - Annual Epidemiological Report for 2019 - EN - [PDF-630.27 KB]
  • EU/EEA
  • Surveillance
  • Zika virus disease

Publication

Tick-borne encephalitis - Annual Epidemiological Report for 2019

Surveillance report - 24 Mar 2021

For 2019, twenty-five EU/EEA countries reported 3 411 cases of tick-borne encephalitis (TBE), 3 246 (95.2%) of which were confirmed.

Tick-borne encephalitis - Annual Epidemiological Report for 2019 - EN - [PDF-518.13 KB]
  • EU/EEA
  • Surveillance
  • Tick-borne encephalitis (TBE)

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy
  • Personal data protection
  • Language policy
  • Cookies
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us